Linked Data API

Show Search Form

Search Results

1279363
registered interest false more like this
date less than 2021-01-21more like thismore than 2021-01-21
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Kawasaki Disease more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of establishing a patient registry on Kawasaki disease. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 141421 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-01-28more like thismore than 2021-01-28
answer text <p>NHS England supports closer monitoring of Kawasaki disease and is now collecting data on incidence monthly, nationally and by region, by assessing finished consultant episodes coded for Kawasaki disease and Kawasaki like disease. In addition, the British Paediatric Surveillance Unit of the Royal College of Paediatrics and Child Health, funded by Public Health England, is conducting a one-year study of all cases of the disease in the United Kingdom and the Republic of Ireland.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill remove filter
question first answered
less than 2021-01-28T15:59:27.263Zmore like thismore than 2021-01-28T15:59:27.263Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
3960
label Biography information for Henry Smith more like this
1279365
registered interest false more like this
date less than 2021-01-21more like thismore than 2021-01-21
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Heart Diseases: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that services for people with heart and circulatory diseases can be provided throughout the covid-19 outbreak to mitigate poorer health outcomes from delays to treatment. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 141422 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-02-02more like thismore than 2021-02-02
answer text <p>On 23 December, NHS England and NHS Improvement published their operational priorities for winter and 2021/22. This confirms that maximising capacity in all settings to treat non-COVID-19 patients and responding to other emergency demands are key priorities for the National Health Service this winter. Cardiac services have been highlighted as a priority area for improvement through developing system-based recovery plans that focus on addressing treatment backlogs and long waits.</p><p> </p><p>To support the NHS in tackling the impact of COVID-19, a £3 billion, one-year package has been announced for 2021/22 as part of the Spending Review. This includes £1 billion to address backlogs and tackle long waiting lists, by facilitating up to one million extra checks, scans and additional operations. Additionally, the NHS is running an ongoing media campaign ‘Help us help you’, which includes clear messaging for patients to call 999 with symptoms of a heart attack or stroke. NHS services will continue to adapt to ensure that they are there for those who need them, as well as launching a major campaign urging people to come forward for help.</p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill remove filter
grouped question UIN 141423 more like this
question first answered
less than 2021-02-02T12:00:55.83Zmore like thismore than 2021-02-02T12:00:55.83Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
3960
label Biography information for Henry Smith more like this
1279368
registered interest false more like this
date less than 2021-01-21more like thismore than 2021-01-21
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Heart Diseases: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what plans he has to build long term capacity in hospitals to allow services to tackle the backlog of care for people with heart and circulatory diseases. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 141423 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-02-02more like thismore than 2021-02-02
answer text <p>On 23 December, NHS England and NHS Improvement published their operational priorities for winter and 2021/22. This confirms that maximising capacity in all settings to treat non-COVID-19 patients and responding to other emergency demands are key priorities for the National Health Service this winter. Cardiac services have been highlighted as a priority area for improvement through developing system-based recovery plans that focus on addressing treatment backlogs and long waits.</p><p> </p><p>To support the NHS in tackling the impact of COVID-19, a £3 billion, one-year package has been announced for 2021/22 as part of the Spending Review. This includes £1 billion to address backlogs and tackle long waiting lists, by facilitating up to one million extra checks, scans and additional operations. Additionally, the NHS is running an ongoing media campaign ‘Help us help you’, which includes clear messaging for patients to call 999 with symptoms of a heart attack or stroke. NHS services will continue to adapt to ensure that they are there for those who need them, as well as launching a major campaign urging people to come forward for help.</p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill remove filter
grouped question UIN 141422 more like this
question first answered
less than 2021-02-02T12:00:55.783Zmore like thismore than 2021-02-02T12:00:55.783Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
3960
label Biography information for Henry Smith more like this
1278587
registered interest false more like this
date less than 2021-01-20more like thismore than 2021-01-20
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many people received (a) chemotherapy and (b) radiotherapy for the treatment of (i) breast cancer, (ii) bowel cancer, (iii) lung cancer, (iv) blood cancer and (v) prostate cancer in each of the last 12 months for which figures are available. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 140773 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-01-27more like thismore than 2021-01-27
answer text <p>The information is not available in the format requested.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill remove filter
question first answered
less than 2021-01-27T14:01:04.29Zmore like thismore than 2021-01-27T14:01:04.29Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
3960
label Biography information for Henry Smith more like this
1270815
registered interest false more like this
date less than 2020-12-14more like thismore than 2020-12-14
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Vaccination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he will take to assess the effectiveness of covid-19 vaccines in immunocompromised people post-vaccination. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 128930 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-12-23more like thismore than 2020-12-23
answer text <p>Prior to the recent authorisation, the efficacy of COVID-19 mRNA Vaccine BNT162b2 was evaluated in two clinical studies. Both studies excluded immunocompromised subjects and therefore no data is available about use of the vaccine when used at the same time as immunosuppressant medicines or the immune response to the vaccine in those on such medications. The second trial allowed inclusion of subjects with autoimmune disorders who were not currently receiving immunosuppressants. There are no specific contraindications or warnings in the product information regarding use in individuals with autoimmune disease.</p><p>Evaluation of data for other vaccines is ongoing but will include a robust review of all quality, safety and efficacy data, including in immunocompromised subjects if they were included in clinical trials.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill remove filter
question first answered
less than 2020-12-23T11:56:22.537Zmore like thismore than 2020-12-23T11:56:22.537Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
3960
label Biography information for Henry Smith more like this
1251465
registered interest false more like this
date less than 2020-11-12more like thismore than 2020-11-12
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Blood Cancer: Coronavirus more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2020 to Question 40578, how many people who are on the shielding list and defined as clinically extremely vulnerable with blood cancer are aged (a) 80 and over (b) between 75 and 79 (c) between 70 and 74 (d) between 65 and 69, (e) between 60 and 64 and (f) 59 or younger. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 114831 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-01-27more like thismore than 2021-01-27
answer text <p>The following table shows a count of patients that are classified as being on the Shielded Patient List (SPL) in England with a blood cancer disease group by age band, as at 3 December 2020.</p><table><tbody><tr><td><p>Age Band</p></td><td><p>Patients on the SPL</p></td></tr><tr><td><p>80 years old and over</p></td><td><p>35,298</p></td></tr><tr><td><p>75-79 years old</p></td><td><p>25,773</p></td></tr><tr><td><p>70-74 years old</p></td><td><p>29,676</p></td></tr><tr><td><p>65-69 years old</p></td><td><p>22,680</p></td></tr><tr><td><p>60-64 years old</p></td><td><p>19,084</p></td></tr><tr><td><p>59 years old or younger</p></td><td><p>55,362</p></td></tr></tbody></table><p> </p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill remove filter
question first answered
less than 2021-01-27T14:50:41.58Zmore like thismore than 2021-01-27T14:50:41.58Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
3960
label Biography information for Henry Smith more like this
1247385
registered interest false more like this
date less than 2020-10-30more like thismore than 2020-10-30
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, when he estimates the evidence-based model to predict risk of death or hospitalisation from covid-19, which has been developed by the University of Oxford, will be in use in the NHS. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 109296 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-12-02more like thismore than 2020-12-02
answer text <p>NHS England and NHS Improvement have been using the University of Oxford’s ‘OpenABM-Covid19’ model for several months and it is used alongside other estimates and projections of hospital admissions including those provided via the Scientific Pandemic Influenza Group on Modelling.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill remove filter
question first answered
less than 2020-12-02T16:54:25.403Zmore like thismore than 2020-12-02T16:54:25.403Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
3960
label Biography information for Henry Smith more like this
1247386
registered interest false more like this
date less than 2020-10-30more like thismore than 2020-10-30
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Vaccination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether people who live in the same home as people who are clinically extremely vulnerable will receive a vaccine for covid-19 before the rest of the general public. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 109297 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-11-18more like thismore than 2020-11-18
answer text <p>Whilst there is a desire for the whole United Kingdom population to be vaccinated, there may need to be an element of prioritisation based on vaccine supply, availability and evidence as data emerges from clinical trials on safety and efficacy in different cohorts of the population.</p><p>The Joint Committee on Vaccination and Immunisation (JCVI) are the independent experts who provide advice to Government on which vaccine(s) the UK should use and which groups within the population to prioritise. The JCVI and the JCVI sub-committee are currently reviewing evidence on clinical risk factors associated with serious disease and mortality from COVID-19. Following a review of the evidence, the Committee will develop advice on risk groups for any future COVID-19 vaccination programme.</p><p>The latest JCVI recommendations on the priority groups for a COVID-19 vaccine is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-25-september-2020" target="_blank">https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-25-september-2020</a></p><p>The minutes of JCVI committee meetings and statements on COVID-19 vaccination are available at the following link:</p><p><a href="https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation" target="_blank">https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation</a></p><p><strong> </strong></p><p> </p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill remove filter
question first answered
less than 2020-11-18T13:04:24.787Zmore like thismore than 2020-11-18T13:04:24.787Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
3960
label Biography information for Henry Smith more like this
1243940
registered interest false more like this
date less than 2020-10-15more like thismore than 2020-10-15
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Bowel Cancer: Coronavirus more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on patient survival rates of delayed diagnosis and screening for colorectal cancer as a result of the covid-19 outbreak. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 104093 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-11-04more like thismore than 2020-11-04
answer text <p>The UK National Screening Committee is undertaking work to estimate the impact of delays to screening programmes, including cancer screening, caused by the COVID-19 pandemic. This work is currently in its early stages and the results will be reported as soon they are available.</p><p>NHS England and NHS Improvement is working to clear the backlog of bowel cancer screening as quickly as possible. All 64 bowel screening centres are now undertaking diagnostic colonoscopies and sending routine screening invitations. As at 5 October 2020, the number of people who have had a faecal immunochemical test-positive result and are awaiting a diagnostic test has nearly halved in comparison to those waiting in April 2020.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill remove filter
question first answered
less than 2020-11-04T11:20:41.307Zmore like thismore than 2020-11-04T11:20:41.307Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
3960
label Biography information for Henry Smith more like this
1243942
registered interest false more like this
date less than 2020-10-15more like thismore than 2020-10-15
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Bowel Cancer more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the care and treatment provided to people with metastatic colorectal cancer in England in light of survival rates being lower than comparable European countries. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 104094 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-11-27more like thismore than 2020-11-27
answer text <p>There is a wide range of treatment options available to manage metastatic colorectal cancer and these are set out within pathway guidance published by the National Institute for Health and Care Excellence.</p><p>While treatment decisions are based on individual clinical circumstances, systemic anti-cancer treatment is the mainstay of care. There are a number of treatments available depending on where the colorectal cancer has spread. For example, where cancer is in the liver, patients may be able to access interventional procedures including laparoscopic resection and ablative treatments as well as radiotherapy (Selective Internal Radiation Therapy and Stereotactic Ablative Radiotherapy).</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill remove filter
question first answered
less than 2020-11-27T12:10:22.23Zmore like thismore than 2020-11-27T12:10:22.23Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
3960
label Biography information for Henry Smith more like this